Clinical trial
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
NCT00000643 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000643 |
|---|---|
| Title | Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients |
| Official title | Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Toxoplasmosis, Cerebral, HIV Infections |
| Intervention type | Drug |
| Interventions | Pyrimethamine, Leucovorin calcium |
| Enrollment | 150 |
| Completion | May 1, 1994 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 2, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: